Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer's disease.
Transl Psychiatry
2017
7
6
e1154
Altered serum fatty acid composition in geriatric depression.
J Neural Transm
2017
124
Suppl 1
119-126
Combined Treatment With Exenatide and Cyclosporine A or Parstatin 1-26 Results in Enhanced Reduction of Infarct Size in a Rabbit Model.
J Cardiovasc Pharmacol
2017
70
1
34-41
Biomarkers and Functional Decline in Prodromal Alzheimer's Disease.
J Alzheimers Dis
2017
58
1
69-78
Additive sex-specific influence of common non-synonymous DISC1 variants on amygdala, basal ganglia, and white cortical surface area in healthy young adults.
Brain Struct Funct
2017
222
2
881-894
Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease.
Alzheimers Dement
2017
13
3
312-321
Modern technology to support carers of care recipients with dementia or functional mental illness: promising progress, but a long road ahead.
Int Psychogeriatr
2017
29
12
1933-1935
Suicide and assisted dying in dementia: what we know and what we need to know. A narrative literature review.
Int Psychogeriatr
2017
29
8
1247-1259
Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias.
Neurology
2017
88
10
961-969
Poly-GP in cerebrospinal fluid linksC9orf72-associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD.
EMBO Mol Med
2017
9
7
859-868